Sintx Technologies, Inc. (SINT)
NASDAQ: SINT · Real-Time Price · USD
2.750
+0.030 (1.10%)
At close: Mar 9, 2026, 4:00 PM EDT
2.820
+0.070 (2.55%)
After-hours: Mar 9, 2026, 4:47 PM EDT
Sintx Technologies Revenue
Sintx Technologies had revenue of $208.00K in the quarter ending September 30, 2025, a decrease of -73.97%. This brings the company's revenue in the last twelve months to $1.27M, down -60.89% year-over-year. In the year 2024, Sintx Technologies had annual revenue of $2.89M with 9.90% growth.
Revenue (ttm)
$1.27M
Revenue Growth
-60.89%
P/S Ratio
8.31
Revenue / Employee
$63,500
Employees
20
Market Cap
10.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.89M | 260.00K | 9.90% |
| Dec 31, 2023 | 2.63M | 1.07M | 68.29% |
| Dec 31, 2022 | 1.56M | 955.00K | 157.59% |
| Dec 31, 2021 | 606.00K | 12.00K | 2.02% |
| Dec 31, 2020 | 594.00K | -95.00K | -13.79% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 48.57M |
| Lifeward | 24.50M |
| Vivos Therapeutics | 17.32M |
| INVO Fertility | 6.94M |
| Beyond Air | 6.92M |
| Intelligent Bio Solutions | 3.58M |
| Tenon Medical | 3.23M |
| Nexalin Technology | 156.93K |
SINT News
- 19 days ago - SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms - GlobeNewsWire
- 5 weeks ago - SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5 - GlobeNewsWire
- 3 months ago - SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants - GlobeNewsWire
- 4 months ago - SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System - GlobeNewsWire
- 5 months ago - SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System - GlobeNewsWire
- 5 months ago - SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics - GlobeNewsWire
- 6 months ago - SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds - GlobeNewsWire
- 6 months ago - SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent - GlobeNewsWire